Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Myriad Genetics (MYGN) Income from Continuing Operations (2016 - 2026)

Myriad Genetics has reported Income from Continuing Operations over the past 17 years, most recently at 7900000.0 for Q4 2025.

  • Quarterly Income from Continuing Operations rose 81.41% to 7900000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 365900000.0 through Dec 2025, down 187.43% year-over-year, with the annual reading at 365900000.0 for FY2025, 187.43% down from the prior year.
  • Income from Continuing Operations was 7900000.0 for Q4 2025 at Myriad Genetics, up from 27400000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 24600000.0 in Q3 2021 and troughed at 330500000.0 in Q2 2025.
  • The 5-year median for Income from Continuing Operations is 29300000.0 (2023), against an average of 44785000.0.
  • Year-over-year, Income from Continuing Operations soared 261.84% in 2021 and then crashed 800.54% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 7600000.0 in 2021, then plummeted by 456.58% to 42300000.0 in 2022, then rose by 26.24% to 31200000.0 in 2023, then tumbled by 36.22% to 42500000.0 in 2024, then soared by 81.41% to 7900000.0 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Income from Continuing Operations are 7900000.0 (Q4 2025), 27400000.0 (Q3 2025), and 330500000.0 (Q2 2025).